25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

ANG (ANG Lifesciences India Ltd) Stock Analysis
Buy, Hold or Sell?

Let's analyze ANG Lifesciences India Ltd together

I guess you are interested in ANG Lifesciences India Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – ANG Lifesciences India Ltd’s Financial Insights
  • 📈 Technical Analysis (TA) – ANG Lifesciences India Ltd’s Price Targets

I'm going to help you getting a better view of ANG Lifesciences India Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about ANG Lifesciences India Ltd

I send you an email if I find something interesting about ANG Lifesciences India Ltd.

1. Quick Overview

1.1. Quick analysis of ANG Lifesciences India Ltd (30 sec.)










1.2. What can you expect buying and holding a share of ANG Lifesciences India Ltd? (30 sec.)

How much money do you get?

How much money do you get?
INR0.00
When do you have the money?
1 year
How often do you get paid?
14.3%

What is your share worth?

Current worth
INR48.99
Expected worth in 1 year
INR11.31
How sure are you?
71.4%

+ What do you gain per year?

Total Gains per Share
INR-37.68
Return On Investment
-129.0%

For what price can you sell your share?

Current Price per Share
INR29.21
Expected price per share
INR21.03 - INR37.22
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of ANG Lifesciences India Ltd (5 min.)




Live pricePrice per Share (EOD)
INR29.21
Intrinsic Value Per Share
INR-57.49 - INR137.62
Total Value Per Share
INR-8.50 - INR186.62

2.2. Growth of ANG Lifesciences India Ltd (5 min.)




Is ANG Lifesciences India Ltd growing?

Current yearPrevious yearGrowGrow %
How rich?$7.4m$8.9m-$1.4m-19.2%

How much money is ANG Lifesciences India Ltd making?

Current yearPrevious yearGrowGrow %
Making money-$1.4m-$1.1m-$265.6k-18.3%
Net Profit Margin-13.4%-6.9%--

How much money comes from the company's main activities?

2.3. Financial Health of ANG Lifesciences India Ltd (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of ANG Lifesciences India Ltd?

Welcome investor! ANG Lifesciences India Ltd's management wants to use your money to grow the business. In return you get a share of ANG Lifesciences India Ltd.

First you should know what it really means to hold a share of ANG Lifesciences India Ltd. And how you can make/lose money.

Speculation

The Price per Share of ANG Lifesciences India Ltd is INR29.21. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of ANG Lifesciences India Ltd.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in ANG Lifesciences India Ltd, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is INR48.99. Based on the TTM, the Book Value Change Per Share is INR-9.42 per quarter. Based on the YOY, the Book Value Change Per Share is INR-7.61 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is INR0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of ANG Lifesciences India Ltd.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 INR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per ShareINR% of Price per Share
Usd Eps-0.11-0.4%-0.11-0.4%-0.09-0.3%-0.07-0.2%0.040.2%0.050.2%
Usd Book Value Change Per Share-0.11-0.4%-0.11-0.4%-0.09-0.3%-0.06-0.2%0.050.2%0.080.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.11-0.4%-0.11-0.4%-0.09-0.3%-0.06-0.2%0.050.2%0.080.3%
Usd Price Per Share0.27-0.27-0.53-0.56-1.09-0.91-
Price to Earnings Ratio-2.39--2.39--5.80--128.98--72.68--49.40-
Price-to-Total Gains Ratio-2.41--2.41--5.92-10.74-11.07-9.19-
Price to Book Ratio0.46-0.46-0.77-0.80-1.75-1.72-
Price-to-Total Gains Ratio-2.41--2.41--5.92-10.74-11.07-9.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.341757
Number of shares2926
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.110.05
Usd Total Gains Per Share-0.110.05
Gains per Quarter (2926 shares)-322.50159.43
Gains per Year (2926 shares)-1,290.01637.70
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-1290-130022616628
20-2580-25904312321266
30-3870-38806518481904
40-5160-51708724642542
50-6450-646010930803180
60-7740-775013036963818
70-9030-904015243124456
80-10320-1033017449285094
90-11610-1162019555445732
100-12900-1291021761606370

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%2.03.00.040.0%4.03.00.057.1%4.03.00.057.1%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.02.00.071.4%5.02.00.071.4%
Dividend per Share0.00.01.00.0%0.00.03.00.0%1.00.04.020.0%1.00.06.014.3%1.00.06.014.3%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%5.02.00.071.4%5.02.00.071.4%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of ANG Lifesciences India Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---9.420-9.4200%-7.612-19%-5.053-46%4.498-309%6.999-235%
Book Value Per Share--48.99348.9930%58.413-16%57.810-15%53.885-9%45.422+8%
Current Ratio--1.1531.1530%1.238-7%1.177-2%1.191-3%1.257-8%
Debt To Asset Ratio--0.7210.7210%0.685+5%0.699+3%0.704+2%0.685+5%
Debt To Equity Ratio--2.5892.5890%2.178+19%2.329+11%2.383+9%2.207+17%
Dividend Per Share----0%-0%-0%0.159-100%0.113-100%
Enterprise Value---1359495424.000-1359495424.0000%-1072927836.000-21%-1117926515.000-18%-452638313.200-67%-336861783.857-75%
Eps---9.506-9.5060%-7.767-18%-5.825-39%3.756-353%3.967-340%
Ev To Sales Ratio---1.464-1.4640%-0.734-50%-0.873-40%-0.455-69%-0.335-77%
Free Cash Flow Per Share---3.068-3.0680%-11.535+276%-0.801-74%-2.277-26%-0.553-82%
Free Cash Flow To Equity Per Share---3.068-3.0680%-11.535+276%-0.801-74%-2.277-26%-1.400-54%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--137.623----------
Intrinsic Value_10Y_min---57.492----------
Intrinsic Value_1Y_max--2.350----------
Intrinsic Value_1Y_min---3.188----------
Intrinsic Value_3Y_max--15.781----------
Intrinsic Value_3Y_min---11.863----------
Intrinsic Value_5Y_max--39.723----------
Intrinsic Value_5Y_min---22.977----------
Market Cap381432943.000+22%296684576.000296684576.0000%588668164.000-50%626145485.000-53%1212463155.000-76%1011924976.429-71%
Net Profit Margin---0.134-0.1340%-0.069-48%-0.068-49%-0.009-93%0.007-1984%
Operating Margin----0%-0%-0%-0%0.025-100%
Operating Ratio--1.7391.7390%1.642+6%1.679+4%1.617+8%1.616+8%
Pb Ratio0.596+22%0.4640.4640%0.772-40%0.796-42%1.748-73%1.722-73%
Pe Ratio-3.073-29%-2.390-2.3900%-5.804+143%-128.981+5297%-72.681+2941%-49.404+1967%
Price Per Share29.210+22%22.72022.7200%45.080-50%47.950-53%92.850-76%77.493-71%
Price To Free Cash Flow Ratio-9.519-29%-7.404-7.4040%-3.908-47%-1.693-77%-0.127-98%3.028-344%
Price To Total Gains Ratio-3.101-29%-2.412-2.4120%-5.922+146%10.741-122%11.074-122%9.186-126%
Quick Ratio--0.5550.5550%0.544+2%0.549+1%0.588-6%0.719-23%
Return On Assets---0.054-0.0540%-0.042-23%-0.032-40%0.018-398%0.032-268%
Return On Equity---0.194-0.1940%-0.133-31%-0.110-43%0.064-403%0.099-296%
Total Gains Per Share---9.420-9.4200%-7.612-19%-5.053-46%4.657-302%7.112-232%
Usd Book Value--7485180.3007485180.3000%8924455.800-16%8832369.000-15%8232662.777-9%6939703.968+8%
Usd Book Value Change Per Share---0.110-0.1100%-0.089-19%-0.059-46%0.053-309%0.082-235%
Usd Book Value Per Share--0.5730.5730%0.683-16%0.676-15%0.630-9%0.531+8%
Usd Dividend Per Share----0%-0%-0%0.002-100%0.001-100%
Usd Enterprise Value---15906096.461-15906096.4610%-12553255.681-21%-13079740.226-18%-5295868.264-67%-3941282.871-75%
Usd Eps---0.111-0.1110%-0.091-18%-0.068-39%0.044-353%0.046-340%
Usd Free Cash Flow---468807.300-468807.3000%-1762394.400+276%-122358.600-74%-347850.468-26%-84514.821-82%
Usd Free Cash Flow Per Share---0.036-0.0360%-0.135+276%-0.009-74%-0.027-26%-0.006-82%
Usd Free Cash Flow To Equity Per Share---0.036-0.0360%-0.135+276%-0.009-74%-0.027-26%-0.016-54%
Usd Market Cap4462765.433+22%3471209.5393471209.5390%6887417.519-50%7325902.175-53%14185818.914-76%11839522.224-71%
Usd Price Per Share0.342+22%0.2660.2660%0.527-50%0.561-53%1.086-76%0.907-71%
Usd Profit---1452356.100-1452356.1000%-1186731.000-18%-889921.500-39%573899.754-353%606230.974-340%
Usd Revenue--10863052.20010863052.2000%17094834.900-36%17890649.400-39%22622240.516-52%20312760.785-47%
Usd Total Gains Per Share---0.110-0.1100%-0.089-19%-0.059-46%0.054-302%0.083-232%
 EOD+5 -3MRQTTM+0 -0YOY+10 -253Y+4 -315Y+3 -3410Y+6 -32

3.3 Fundamental Score

Let's check the fundamental score of ANG Lifesciences India Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-3.073
Price to Book Ratio (EOD)Between0-10.596
Net Profit Margin (MRQ)Greater than0-0.134
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.555
Current Ratio (MRQ)Greater than11.153
Debt to Asset Ratio (MRQ)Less than10.721
Debt to Equity Ratio (MRQ)Less than12.589
Return on Equity (MRQ)Greater than0.15-0.194
Return on Assets (MRQ)Greater than0.05-0.054
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of ANG Lifesciences India Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.048
Ma 20Greater thanMa 5029.118
Ma 50Greater thanMa 10028.453
Ma 100Greater thanMa 20029.932
OpenGreater thanClose29.010
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About ANG Lifesciences India Ltd

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit ANG Lifesciences India Ltd earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare ANG Lifesciences India Ltd to the  industry mean.
  • A Net Profit Margin of -13.4% means that ₹-0.13 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of ANG Lifesciences India Ltd:

  • The MRQ is -13.4%. The company is making a huge loss. -2
  • The TTM is -13.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-13.4%TTM-13.4%0.0%
TTM-13.4%YOY-6.9%-6.4%
TTM-13.4%5Y-0.9%-12.5%
5Y-0.9%10Y0.7%-1.6%
4.3.1.2. Return on Assets

Shows how efficient ANG Lifesciences India Ltd is using its assets to generate profit.

  • Above 5% is considered healthy but always compare ANG Lifesciences India Ltd to the  industry mean.
  • -5.4% Return on Assets means that ANG Lifesciences India Ltd generated ₹-0.05 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of ANG Lifesciences India Ltd:

  • The MRQ is -5.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -5.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.4%TTM-5.4%0.0%
TTM-5.4%YOY-4.2%-1.2%
TTM-5.4%5Y1.8%-7.2%
5Y1.8%10Y3.2%-1.4%
4.3.1.3. Return on Equity

Shows how efficient ANG Lifesciences India Ltd is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare ANG Lifesciences India Ltd to the  industry mean.
  • -19.4% Return on Equity means ANG Lifesciences India Ltd generated ₹-0.19 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of ANG Lifesciences India Ltd:

  • The MRQ is -19.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -19.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.4%TTM-19.4%0.0%
TTM-19.4%YOY-13.3%-6.1%
TTM-19.4%5Y6.4%-25.8%
5Y6.4%10Y9.9%-3.5%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of ANG Lifesciences India Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient ANG Lifesciences India Ltd is operating .

  • Measures how much profit ANG Lifesciences India Ltd makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare ANG Lifesciences India Ltd to the  industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of ANG Lifesciences India Ltd:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y2.5%-2.5%
4.3.2.2. Operating Ratio

Measures how efficient ANG Lifesciences India Ltd is keeping operating costs low.

  • Below 1 is considered healthy (always compare to  industry mean).
  • An Operation Ratio of 1.74 means that the operating costs are ₹1.74 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of ANG Lifesciences India Ltd:

  • The MRQ is 1.739. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.739. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.739TTM1.7390.000
TTM1.739YOY1.642+0.097
TTM1.7395Y1.617+0.123
5Y1.61710Y1.616+0.001
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of ANG Lifesciences India Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if ANG Lifesciences India Ltd is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to  industry mean).
  • A Current Ratio of 1.15 means the company has ₹1.15 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of ANG Lifesciences India Ltd:

  • The MRQ is 1.153. The company is just able to pay all its short-term debts.
  • The TTM is 1.153. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.153TTM1.1530.000
TTM1.153YOY1.238-0.085
TTM1.1535Y1.191-0.038
5Y1.19110Y1.257-0.066
4.4.3.2. Quick Ratio

Measures if ANG Lifesciences India Ltd is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare ANG Lifesciences India Ltd to the  industry mean.
  • A Quick Ratio of 0.56 means the company can pay off ₹0.56 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of ANG Lifesciences India Ltd:

  • The MRQ is 0.555. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.555. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.555TTM0.5550.000
TTM0.555YOY0.544+0.011
TTM0.5555Y0.588-0.033
5Y0.58810Y0.719-0.131
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of ANG Lifesciences India Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of ANG Lifesciences India Ltd assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare ANG Lifesciences India Ltd to industry mean.
  • A Debt to Asset Ratio of 0.72 means that ANG Lifesciences India Ltd assets are financed with 72.1% credit (debt) and the remaining percentage (100% - 72.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of ANG Lifesciences India Ltd:

  • The MRQ is 0.721. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.721. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.721TTM0.7210.000
TTM0.721YOY0.685+0.036
TTM0.7215Y0.704+0.018
5Y0.70410Y0.685+0.019
4.5.4.2. Debt to Equity Ratio

Measures if ANG Lifesciences India Ltd is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare ANG Lifesciences India Ltd to the  industry mean.
  • A Debt to Equity ratio of 258.9% means that company has ₹2.59 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of ANG Lifesciences India Ltd:

  • The MRQ is 2.589. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.589. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.589TTM2.5890.000
TTM2.589YOY2.178+0.410
TTM2.5895Y2.383+0.205
5Y2.38310Y2.207+0.177
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings ANG Lifesciences India Ltd generates.

  • Above 15 is considered overpriced but always compare ANG Lifesciences India Ltd to the  industry mean.
  • A PE ratio of -2.39 means the investor is paying ₹-2.39 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of ANG Lifesciences India Ltd:

  • The EOD is -3.073. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.390. Based on the earnings, the company is expensive. -2
  • The TTM is -2.390. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-3.073MRQ-2.390-0.683
MRQ-2.390TTM-2.3900.000
TTM-2.390YOY-5.804+3.414
TTM-2.3905Y-72.681+70.291
5Y-72.68110Y-49.404-23.276
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of ANG Lifesciences India Ltd:

  • The EOD is -9.519. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.404. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -7.404. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.519MRQ-7.404-2.115
MRQ-7.404TTM-7.4040.000
TTM-7.404YOY-3.908-3.496
TTM-7.4045Y-0.127-7.277
5Y-0.12710Y3.028-3.156
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of ANG Lifesciences India Ltd is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to industry mean).
  • A PB ratio of 0.46 means the investor is paying ₹0.46 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of ANG Lifesciences India Ltd:

  • The EOD is 0.596. Based on the equity, the company is cheap. +2
  • The MRQ is 0.464. Based on the equity, the company is cheap. +2
  • The TTM is 0.464. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.596MRQ0.464+0.132
MRQ0.464TTM0.4640.000
TTM0.464YOY0.772-0.308
TTM0.4645Y1.748-1.284
5Y1.74810Y1.722+0.025
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2021-03-312022-03-312023-03-312024-03-312025-03-31
Operating Income  141,488494,759636,247-568,15768,090-55,28512,805-103,082-90,277



6.2. Latest Balance Sheet

Balance Sheet of 2025-03-31. Currency in INR. All numbers in thousands.

Summary
Total Assets2,295,939
Total Liabilities1,656,180
Total Stockholder Equity639,759
 As reported
Total Liabilities 1,656,180
Total Stockholder Equity+ 639,759
Total Assets = 2,295,939

Assets

Total Assets2,295,939
Total Current Assets1,653,397
Long-term Assets642,542
Total Current Assets
Cash And Cash Equivalents 1,573
Short-term Investments 131,180
Net Receivables 665,389
Inventory 541,091
Other Current Assets 271,065
Total Current Assets  (as reported)1,653,397
Total Current Assets  (calculated)1,610,298
+/- 43,099
Long-term Assets
Property Plant Equipment 571,930
Long-term Assets Other 2,903
Long-term Assets  (as reported)642,542
Long-term Assets  (calculated)574,833
+/- 67,709

Liabilities & Shareholders' Equity

Total Current Liabilities1,434,364
Long-term Liabilities221,816
Total Stockholder Equity639,759
Total Current Liabilities
Short Long Term Debt 615,719
Accounts payable 660,741
Other Current Liabilities 101,382
Total Current Liabilities  (as reported)1,434,364
Total Current Liabilities  (calculated)1,377,842
+/- 56,522
Long-term Liabilities
Long term Debt 188,608
Capital Lease Obligations Min Short Term Debt27,733
Long-term Liabilities  (as reported)221,816
Long-term Liabilities  (calculated)216,341
+/- 5,475
Total Stockholder Equity
Total Stockholder Equity (as reported)639,759
Total Stockholder Equity (calculated)0
+/- 639,759
Other
Capital Stock130,583
Common Stock Shares Outstanding 13,058
Net Debt 802,754
Net Invested Capital 1,444,086
Net Working Capital 219,033
Property Plant and Equipment Gross 571,930



6.3. Balance Sheets Structured

Currency in INR. All numbers in thousands.

 Trend2025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
> Total Assets 
0
0
808,976
940,751
1,436,509
2,910,304
2,776,617
2,424,370
2,295,939
2,295,9392,424,3702,776,6172,910,3041,436,509940,751808,97600
   > Total Current Assets 
377,572
468,746
599,590
727,129
1,158,691
1,928,121
1,848,525
1,789,363
1,653,397
1,653,3971,789,3631,848,5251,928,1211,158,691727,129599,590468,746377,572
       Cash And Cash Equivalents 
0
0
43,715
36,005
1,437
3,460
3,242
3,185
1,573
1,5733,1853,2423,4601,43736,00543,71500
       Short-term Investments 
0
0
0
0
0
63,062
58,533
54,167
131,180
131,18054,16758,53363,06200000
       Net Receivables 
257,216
354,620
442,218
533,156
587,433
1,020,550
831,482
732,775
665,389
665,389732,775831,4821,020,550587,433533,156442,218354,620257,216
       Inventory 
58,408
77,429
65,373
100,043
192,587
369,591
484,871
477,660
541,091
541,091477,660484,871369,591192,587100,04365,37377,42958,408
       Other Current Assets 
52,708
21,622
48,000
57,925
107,873
110
334,889
349,500
271,065
271,065349,500334,889110107,87357,92548,00021,62252,708
   > Long-term Assets 
0
0
209,386
422,996
277,818
982,183
928,092
635,008
642,542
642,542635,008928,092982,183277,818422,996209,38600
       Property Plant Equipment 
89,730
208,784
205,965
209,373
238,649
928,457
883,790
586,283
571,930
571,930586,283883,790928,457238,649209,373205,965208,78489,730
       Intangible Assets 
0
0
0
2,312
2,312
0
0
0
0
00002,3122,312000
       Long-term Assets Other 
0
0
1,592
1,737
1,245
-2
-3
-2
2,903
2,903-2-3-21,2451,7371,59200
> Total Liabilities 
0
0
521,303
594,697
1,020,678
2,072,613
1,914,440
1,661,596
1,656,180
1,656,1801,661,5961,914,4402,072,6131,020,678594,697521,30300
   > Total Current Liabilities 
342,107
354,460
424,044
508,969
915,613
1,662,893
1,622,840
1,445,666
1,434,364
1,434,3641,445,6661,622,8401,662,893915,613508,969424,044354,460342,107
       Short Long Term Debt 
0
0
156,240
155,645
361,320
553,581
494,445
552,958
615,719
615,719552,958494,445553,581361,320155,645156,24000
       Accounts payable 
213,918
223,152
218,146
257,896
400,402
706,290
681,862
661,786
660,741
660,741661,786681,862706,290400,402257,896218,146223,152213,918
       Other Current Liabilities 
19,849
15,500
28,425
121,879
135,353
75,002
-1
9,999
101,382
101,3829,999-175,002135,353121,87928,42515,50019,849
   > Long-term Liabilities 
0
0
97,260
86,227
105,066
409,720
291,600
215,930
221,816
221,816215,930291,600409,720105,06686,22797,26000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
28,091
35,915
27,733
27,73335,91528,091000000
       Long-term Liabilities Other 
0
0
4,008
3,621
2,857
0
-1
0
0
00-102,8573,6214,00800
> Total Stockholder Equity
0
0
287,673
346,055
415,831
837,691
862,177
762,774
639,759
639,759762,774862,177837,691415,831346,055287,67300
   Retained Earnings 
36,566
73,794
130,284
188,666
258,942
621,022
625,508
526,105
0
0526,105625,508621,022258,942188,666130,28473,79436,566
   Accumulated Other Comprehensive Income 000000000
   Capital Surplus 000000000
   Treasury Stock000000000



6.4. Balance Sheets

Currency in INR. All numbers in thousands.




6.5. Cash Flows

Currency in INR. All numbers in thousands.




6.6. Income Statements

Currency in INR. All numbers in thousands.


6.7. Latest Income Statement

Income Statement (annual), 2025-03-31. Currency in INR. All numbers in thousands.

Gross Profit (+$)
totalRevenue928,466
Cost of Revenue-596,227
Gross Profit332,239332,239
 
Operating Income (+$)
Gross Profit332,239
Operating Expense-1,018,743
Operating Income-90,277-686,504
 
Operating Expense (+$)
Research Development0
Selling General Administrative0
Selling And Marketing Expenses0
Operating Expense1,018,7430
 
Net Interest Income (+$)
Interest Income0
Interest Expense-86,878
Other Finance Cost-0
Net Interest Income-86,878
 
Pretax Income (+$)
Operating Income-90,277
Net Interest Income-86,878
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-157,037-90,277
EBIT - interestExpense = -86,878
-124,133
-37,255
Interest Expense86,878
Earnings Before Interest and Taxes (EBIT)0-70,159
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-157,037
Tax Provision--32,904
Net Income From Continuing Ops-124,133-124,133
Net Income-124,133
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net086,878
 

Technical Analysis of ANG Lifesciences India Ltd
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of ANG Lifesciences India Ltd. The general trend of ANG Lifesciences India Ltd is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine ANG Lifesciences India Ltd's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. ANG Lifesciences India Ltd Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of ANG Lifesciences India Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 31.10 < 32.84 < 37.22.

The bearish price targets are: 27.66 > 25.50 > 21.03.

Know someone who trades $ANG? Share this with them.👇

ANG Lifesciences India Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of ANG Lifesciences India Ltd. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

ANG Lifesciences India Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of ANG Lifesciences India Ltd. The current macd is -0.12097485.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the ANG Lifesciences India Ltd price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for ANG Lifesciences India Ltd. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the ANG Lifesciences India Ltd price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
ANG Lifesciences India Ltd Daily Moving Average Convergence/Divergence (MACD) ChartANG Lifesciences India Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of ANG Lifesciences India Ltd. The current adx is 19.99.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy ANG Lifesciences India Ltd shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
ANG Lifesciences India Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of ANG Lifesciences India Ltd. The current sar is 29.51.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
ANG Lifesciences India Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of ANG Lifesciences India Ltd. The current rsi is 54.05. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 4/13.
The longshort score for the Relative Strength Index (RSI) is 4/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending up: The RSI is trending up. +1
ANG Lifesciences India Ltd Daily Relative Strength Index (RSI) ChartANG Lifesciences India Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of ANG Lifesciences India Ltd. The current phase is Correction in bear market.

The long score for the Stochastic Oscillator is 4/6.
The longshort score for the Stochastic Oscillator is 4/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the ANG Lifesciences India Ltd price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
ANG Lifesciences India Ltd Daily Stochastic Oscillator ChartANG Lifesciences India Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of ANG Lifesciences India Ltd. The current cci is 7.88153074.

ANG Lifesciences India Ltd Daily Commodity Channel Index (CCI) ChartANG Lifesciences India Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of ANG Lifesciences India Ltd. The current cmo is 15.98.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
ANG Lifesciences India Ltd Daily Chande Momentum Oscillator (CMO) ChartANG Lifesciences India Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of ANG Lifesciences India Ltd. The current willr is -36.47540984.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that ANG Lifesciences India Ltd is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
ANG Lifesciences India Ltd Daily Williams %R ChartANG Lifesciences India Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of ANG Lifesciences India Ltd.

ANG Lifesciences India Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of ANG Lifesciences India Ltd. The current atr is 0.74865162.

ANG Lifesciences India Ltd Daily Average True Range (ATR) ChartANG Lifesciences India Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of ANG Lifesciences India Ltd. The current obv is -355,775.

ANG Lifesciences India Ltd Daily On-Balance Volume (OBV) ChartANG Lifesciences India Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of ANG Lifesciences India Ltd. The current mfi is 79.62.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
ANG Lifesciences India Ltd Daily Money Flow Index (MFI) ChartANG Lifesciences India Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for ANG Lifesciences India Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-06SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-18STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-03-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-18RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-20STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-26STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-27MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-01RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-04-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-04-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-09WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-17CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-04-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-04-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-02STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-07CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-05-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-20MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-28STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-05CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-06-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-10STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-18MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-20WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-24STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-25STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-06-26STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-30DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-07-01CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).

6.3. Candlestick Patterns

ANG Lifesciences India Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of ANG Lifesciences India Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.048
Ma 20Greater thanMa 5029.118
Ma 50Greater thanMa 10028.453
Ma 100Greater thanMa 20029.932
OpenGreater thanClose29.010
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of ANG Lifesciences India Ltd with someone you think should read this too:
  • Are you bullish or bearish on ANG Lifesciences India Ltd? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about ANG Lifesciences India Ltd? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about ANG Lifesciences India Ltd

I send you an email if I find something interesting about ANG Lifesciences India Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about ANG Lifesciences India Ltd.

Receive notifications about ANG Lifesciences India Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.